Dudediligence.

uniQure N.V.

QURENASDAQ · Pharmaceutical Preparations
Write an idea

Price

From the filings

Figures

Revenue
$18.7Mlast 12 months
Net income
−$252.2Mlast 12 months
Operating cash flow
−$172.1Mlast 12 months
Cash and equivalents
$413.0Mat the last balance sheet
Total debt
$50.1Mat the last balance sheet
Shares outstanding
69.3M shareson issue
Every year and quarter →